Dubermatinib
- Generic Name
- Dubermatinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H30ClN7O2S
- CAS Number
- 1341200-45-0
- Unique Ingredient Identifier
- 14D65TV20J
- Background
Dubermatinib is under investigation in clinical trial NCT03572634 (Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath